Gibson Dunn Advised Natera on Acquisition of Foresight Diagnostics

Gibson Dunn Advised Natera on Acquisition of Foresight Diagnostics

Gibson Dunn advised Natera, Inc., a global leader in cell-free DNA and precision medicine, on its acquisition of Foresight Diagnostics, a leader in ultrasensitive molecular residual disease detection.

The Gibson Dunn team was led by included Branden Berns (Partner), Gina Hancock (Partner), Jin Hee Kim (Partner).

Click to know more about Gibson dunn

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.